The American Journal of Medicine
Volume 122, Issue 6 , Pages 581.e11-581.e19, June 2009

Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score

  • Ignacio Cruz-Gonzalez, MD, PhD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    • Both authors contributed equally.
    • Corresponding Author InformationRequests for reprints should be addressed to Ignacio Cruz-Gonzalez, MD, PhD, Cardiac Catheterization Laboratory, Massachusetts General Hospital, GRB 800, 55 Fruit Street, Boston, MA, 02114
  • ,
  • Maria Sanchez-Ledesma, MD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    • Both authors contributed equally.
  • ,
  • Pedro L. Sanchez, MD, PhD

      Affiliations

    • Servicio de Cardiología, Hospital Universitario Gregorio Marañón, Madrid, España
  • ,
  • Javier Martin-Moreiras, MD

      Affiliations

    • Servicio de Cardiología. Hospital Universitario de Salamanca, Salamanca, España
  • ,
  • Hani Jneid, MD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
  • ,
  • Pablo Rengifo-Moreno, MD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
  • ,
  • Ignacio Inglessis-Azuaje, MD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
  • ,
  • Andrew O. Maree, MD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
  • ,
  • Igor F. Palacios, MD

      Affiliations

    • Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Abstract 

Background

Percutaneous mitral valvuloplasty (PMV) success depends on appropriate patient selection. A multifactorial score derived from clinical, anatomic/echocardiographic, and hemodynamic variables would predict procedural success and clinical outcome.

Methods

Demographic data, echocardiographic parameters (including echocardiographic score), and procedure-related variables were recorded in 1085 consecutive PMVs. Long-term clinical follow-up (death, mitral valve replacement, redo PMV) was performed. Multivariate regression analysis of the first 800 procedures was performed to identify independent predictors of procedural success. Significant variables were formulated into a risk score and validated prospectively.

Results

Six independent predictors of PMV success were identified: age less than 55 years, New York Heart Association classes I and II, pre-PMV mitral area of 1 cm2 or greater, pre-PMV mitral regurgitation grade less than 2, echocardiographic score of 8 or greater, and male sex. A score was constructed from the arithmetic sum of variables present per patient. Procedural success rates increased incrementally with increasing score (0% for 0/6, 39.7% for 1/6, 54.4% for 2/6, 77.3% for 3/6, 85.7% for 4/6, 95% for 5/6, and 100% for 6/6; P < .001). In a validation cohort (n = 285 procedures), the multifactorial score remained a significant predictor of PMV success (P < .001). Comparison between the new score and the echocardiographic score confirmed that the new index was more sensitive and specific (P < .001). This new score also predicts long-term outcomes (P < .001).

Conclusion

Clinical, anatomic, and hemodynamic variables predict PMV success and clinical outcome and may be formulated in a scoring system that would help to identify the best candidates for PMV.

Keywords: Percutaneous mitral valvuloplasty, Prognosis, Score

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding: Dr Cruz-Gonzalez acknowledges the support and funding of the Spanish Society of Cardiology (Hemodynamic section) and Medtronic Iberia S.A. Drs Cruz-Gonzalez and Sanchez-Ledesma acknowledge the support of the University Hospital of Salamanca.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(08)01260-6

doi:10.1016/j.amjmed.2008.10.038

The American Journal of Medicine
Volume 122, Issue 6 , Pages 581.e11-581.e19, June 2009